Amgen
Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the world's largest independent biotechnology companies, Amgen's Thousand Oaks staff in 2022 numbered approximately 5,000 (8.5% of total city employment) and included hundreds of scientists, making Amgen the largest employer in Ventura County. As of 2022, Amgen has approximately 24,000 staff in total.
Headquarters in Thousand Oaks, California | |
| Formerly | Applied Molecular Genetics (1980–1983) |
|---|---|
| Company type | Public |
| ISIN | US0311621009 |
| Industry | Biotechnology |
| Founded | April 8, 1980 |
| Headquarters | Thousand Oaks, California, U.S. |
Key people | Robert A. Bradway (chairman, president & CEO) |
| Products | |
| Revenue | US$28.19 billion (2023) |
| US$7.897 billion (2023) | |
| US$6.717 billion (2023) | |
| Total assets | US$97.15 billion (2023) |
| Total equity | US$6.232 billion (2023) |
Number of employees | c. 26,700 (2023) |
| Website | amgen |
| Footnotes / references | |
In 2019, the company's largest selling products were Enbrel (etanercept), a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases, and Neulasta (pegfilgrastim), an immunostimulator used to prevent infections in patients undergoing cancer chemotherapy. Other marketed products include Evenity (romosozumab-aqqg), Otezla (apremilast), Prolia (denosumab), Repatha (evolocumab), and Lumakras (sotorasib).